R&D Systems Inc. Tocris Bioscience Boston Biochem

All Products

Displaying products alphabetically by name (E)

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Cat.No.
Product Name / Activity
4545E 64d

Cathepsin inhibitor; interferes with autolysosomal digestion

1808E-4031 dihydrochloride

KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr)

1009E4CPG

Group I/group II mGlu antagonist

4876Eact

Activator of Ca2+-activated Cl- channel transmembrane protein 16A (TMEM16A)

3993EB 1089

Vitamin D receptor (VDR) agonist

4140EB 47

Potent PARP-1 inhibitor

10411-EBIO

Activator of epithelial KCa channels

0518EBPC

Aldose reductase inhibitor

4011EC 23

Synthetic retinoid; induces differentiation of stem cells

3202Echistatin, α1 isoform

αVβ3 and glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor

0786Edaravone

Anti-ischemic and antioxidant

3022Edelfosine

Selective PI-PLC inhibitor, also PAF receptor agonist

2811EDTA

Chelating agent

3922Eeyarestatin I

Potent inhibitor of ER-associated protein degradation and translocation

0792Efaroxan hydrochloride

α2 antagonist and I1, I3 ligand

3733Efonidipine hydrochloride monoethanolate

Ca2+ channel blocker (L- and T-type)

4524EGCG

Inhibits formation of amyloid fibrils

0971EGLU

Highly selective group II mGlu antagonist

2807EGTA

Calcium chelating agent

1261EHNA hydrochloride

Adenosine deaminase inhibitor

3872EHT 1864

Potent inhibitor of Rac family GTPases

3378EIPA

Inhibits TRPP3-mediated currents; also inhibits the Na+/H+ exchanger (NHE)

0873EIT hydrobromide

Selective iNOS inhibitor, acts arginine binding site

4646Elacridar hydrochloride

P-gp inhibitor

1914Eledoisin

Potent tachykinin receptor ligand

1920Eledoisin-Related Peptide

Tachykinin receptor ligand

3862Eletriptan hydrobromide

Orally active, selective 5-HT1B/1D agonist

2195Eliprodil

Non-competitive NR2B-selective NMDA antagonist

3058Ellagic acid

Selective inhibitor of CK2. Also inhibits glutathione S-transferase

3357Ellipticine

Antitumor and intercalating agent; inhibits DNA topoisomerase II

1860Eltoprazine hydrochloride

5-HT1 receptor agonist/partial agonist

2156Embelin

Inhibitor of X-linked inhibitor of apoptosis (XIAP); cell-permeable and antitumor

4470EMD 281014 hydrochloride

Selective 5-HT2A antagonist

2382EMD 386088 hydrochloride

Potent 5-HT6 agonist

1849EMD 66684

Potent, selective non-peptide AT1 antagonist

4209EMDT oxalate

Selective 5-HT6 agonist

3811Emodin

Naturally occurring anthraquinone; displays anti-inflammatory, antitumor and neuroprotective activity

4558EMPA

Highly potent and selective OX2 antagonist; brain penetrant

3576(±)-5'-Chloro-5'-deoxy-ENBA

Highly selective A1 agonist

2180Endocannabinoid Tocriset™

Selection of 4 endogenous cannabinoids (Cat. Nos. 1339, 1568, 1411 and 1569)

1055Endomorphin-1

Potent and selective μ agonist

1056Endomorphin-2

Potent and selective μ agonist

1160Endothelin 1 (human, porcine)

Potent vasoconstrictor peptide

1164Endothelin 2 (human)

ETA/ETB agonist

1162Endothelin 3 (human, rat)

Potent vasoconstrictor

1197[Ala1,3,11,15]-Endothelin

Selective ETB agonist

3705Endoxifen

Potent antiestrogen; ERα ligand

1889[Leu5]-Enkephalin

Endogenous opioid agonist peptide

1693Enoximone

PDE3 inhibitor

4720Entacapone

Potent COMT inhibitor; blocks α-synuclein aggregation

3612Enterostatin

Binds to β-subunit of F1-ATPase; anorexigenic peptide

2908EO 1428

Selective inhibitor of p38α and p38β2

0684(±)-Epibatidine

Very potent nicotinic agonist

3260Epirubicin hydrochloride

Inhibits DNA synthesis and function. Inhibits DNA topoisomerase II

2397Eplerenone

Selective mineralocorticoid receptor antagonist

2989Epoprostenol

Endogenous IP receptor agonist

3502Epothilone B

Microtubule stabilization agent; promotes tubulin polymerization

4696Eprosartan mesylate

Potent and selective AT1 receptor antagonist

4725Eptifibatide

Glycoprotein IIa/IIIb inhibitor; inhibits platelet aggregation

2471ER 27319 maleate

Selective Syk kinase inhibitor

3823ER 50891

Selective RARα antagonist

4276ERB 041

Potent ERβ agonist

4146Ercalcidiol

Metabolite of vitamin D2

3970Ercalcitriol

Active metabolite of vitamin D2

4022ES 936

Mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase (NQO1)

4796Escitalopram oxalate

Selective serotonin reuptake inhibitor (SSRI)

2823α-Estradiol

Endogenous estrogen receptor agonist

2824β-Estradiol

Endogenous ER agonist

3588Estropipate

Estrogen receptor agonist and OATP1B1 inhibitor

0438Etazolate hydrochloride

PDE4 inhibitor

1847Eticlopride hydrochloride

Selective D2/D3 antagonist

3113Etifoxine hydrochloride

Potentiator of GABAA receptors; anxiolytic

3871Etodolac

Selective cyclooxygenase-2 (COX-2) inhibitor; NSAID

1471Etomidate

GABA mimetic and GABA modulatory agent

4539(R)-(+)-Etomoxir sodium salt

Carnitine palmitoyltransferase I (CPT1) inhibitor

0516Etonitazenyl isothiocyanate

Irreversible affinity label (μ selective)

1226Etoposide

Topoisomerase II inhibitor

0845Evans Blue tetrasodium salt

Potent inhibitor of L-glutamate uptake into synaptic vesicles

2780EX 527

Selective SIRT1 inhibitor

1830Excitatory Amino Acid Transporter Inhibitor Tocriset™

Selection of 5 EAAT inhibitors (Cat. Nos. 0183, 0298, 1223, 0111 and 0903)

3759Exemestane

Steroidal aromatase (CYP19) inhibitor

2081Exendin-3 (9-39) amide

Potent GLP-1 receptor antagonist

1933Exendin-4

Potent GLP-1 receptor agonist

1850Exo1

Inhibits Golgi-ER traffic; blocks exocytosis

Products by Catalog Number

0100 0200 0300 0400 0500 0600 0700 0800 0900 1000
1100 1200 1300 1400 1500 1600 1700 1800 1900 2000
2100 2200 2300 2400 2500 2600 2700 2800 2900 3000
3100 3200 3300 3400 3500 3600 3700 3800 3900 4000
4100 4200 4300 4400 4500 4600 4700 4800

[top]

Quick Order

Find multiple products by catalog number

divider line

New Product E-alerts

Sign up for email updates from Tocris

Sign-up for New Product E-alerts

Enter your email address below to sign up to receive our email updates:

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions